Evidence is growing that psychedelics could hold the key to managing inflammation, one of the body’s central drivers of many ...

The US Food and Drug Administration (FDA) has approved AbbVie’s supplemental new drug application, updating the indication ...

Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and Prevention reports that it kills more than 52,000 people a year in the United ...

Intracerebral hemorrhages (ICH) account for 15% of strokes but a disproportionate 50% of all stroke deaths. An ICH occurs ...

A silent epidemic of chronic inflammation affects nearly half of adults worldwide. This condition is now linked to about 60 ...

ABIVAX Société Anonyme's Obefazimod shows robust efficacy and differentiation in early Phase 3 trials. Click here to read why ...

Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin—a ...

Key Takeaways StemWave acoustic therapy shows an 85-90% improvement rate for knee pain patients through non-invasive ...

Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose ...

Mitochondria isolated from onions entered lung immune cells in mice and restored their energy balance, revealing an ...

UC study explores post-stroke inflammation and its dual role in damage and repair, aiming to improve treatment for ...

Researchers have identified a rare type of brain cell that may drive the chronic inflammation and neurodegeneration seen in progressive multiple sclerosis (MS).